Tech Company Financing Transactions
Science 37 Funding Round
On 10/19/2016, Science 37 raised $31 million in Series B funding from Redmile Group, dRx Capital and Lux Capital.
Transaction Overview
Company Name
Announced On
10/19/2016
Transaction Type
Venture Equity
Amount
$31,000,000
Round
Series B
Investors
Redmile Group (Lead Investor) (Rob Faulkner)
dRx Capital (Lucian Iancovici)
Lux Capital (Adam Goulburn)
Proceeds Purpose
The investment will help the company grow operations, further develop its novel technology platform and continue to expand into new therapeutic areas.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
12121 Bluff Creek Dr. 100
Los Angeles, CA 90094
USA
Los Angeles, CA 90094
USA
Phone
Website
Email Address
Overview
At Science 37, we don't see diseases, we see people -- the patients who are suffering and the physician-scientists trying to help. S37 was created to help patients access the most advanced research available to help with their health problems.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Coman
Chief Financial Officer
Michael Zaranek
Chief Medical Officer
Jonathan Cotliar
Vice President
Jonathan Commons
Vice President
Darcy Forman
VP - Administration
Adriana Centeno
VP - Bus. Development
Steve Geffon
VP - General Counsel
Laura Podolsky
VP - Product Management
Chris Ceppi
Browse more venture capital transactions:
Prev: 10/19/2016: Chorus.ai venture capital transaction
Next: 10/19/2016: Happiest Baby venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs